Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder - Related Studies

Comparison of Antipsychotics for Metabolic Problems in the Treatment of People With Schizophrenia or Schizoaffective Disorder (CAMP)

This study is currently recruiting participants.

Study NCT00423878. Last updated on August 21, 2008. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Schizophrenia
		Schizoaffective Disorder

2	Additional conditions recognized in this trial
		Disease
		Psychotic Disorders

3	More general conditions related to this trial
		Mental Disorders
		Pathologic Processes
		Schizophrenia and Disorders with Psychotic Features

4	Interventions listed in this trial
		Risperidone
		Olanzapine
		Quetiapine
		Aripiprazole

5	More general drug interventions related to this trial
		Antiemetics
		Antipsychotic Agents
		Autonomic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Dopamine Agents
		Dopamine Antagonists
		Gastrointestinal Agents
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Antagonists
		Serotonin Uptake Inhibitors
		Therapeutic Uses
		Tranquilizing Agents

6	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)